Biotech MavenHot Analyst Reads4 Hot Analyst Reads For Thursday, June 14thBiotech MavenMaxim Group Maintains Their Buy Rating on Viveve Medical Inc - MarketsMaxim Group analyst Anthony Vendetti maintained a Buy rating on Viveve Medical Inc (NASDAQ: VIVE) today and set a pricewww.markets.co